KYPROLIS for Plasma cell myeloma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 61 adverse event reports in the FDA FAERS database where KYPROLIS was used for Plasma cell myeloma.
Most Reported Side Effects for KYPROLIS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 17 | 20.0% | 17 | 2 |
| Pneumonia | 12 | 14.1% | 5 | 10 |
| Dyspnoea | 10 | 11.8% | 3 | 7 |
| Disease progression | 9 | 10.6% | 7 | 3 |
| Cardiac failure congestive | 7 | 8.2% | 2 | 5 |
| Dehydration | 7 | 8.2% | 0 | 7 |
| Fatigue | 6 | 7.1% | 2 | 5 |
| Haemoglobin decreased | 6 | 7.1% | 3 | 3 |
| Plasma cell myeloma | 6 | 7.1% | 4 | 3 |
| Platelet count decreased | 6 | 7.1% | 3 | 3 |
| White blood cell count decreased | 6 | 7.1% | 3 | 6 |
Other Indications for KYPROLIS
Other Drugs Used for Plasma cell myeloma
LENALIDOMIDE (273,951)
POMALIDOMIDE (81,096)
DEXAMETHASONE (49,067)
BORTEZOMIB (31,567)
DARATUMUMAB (19,119)
IXAZOMIB (17,602)
CARFILZOMIB (15,333)
THALIDOMIDE (10,689)
CYCLOPHOSPHAMIDE (9,148)
REVLIMID (7,122)